Tag: COVID
Indian Immunologicals holds scientific conclave on pandemic preparedness & vaccine innovation
The objective of this conclave was to ideate, explore and collaborate on the learnings of the pandemic, and to build a more robust & resilient health care system
ICMR signs MOAs with industry & academic partners to advance first-in-human...
The partnership marks a pivotal step towards establishing India’s self-sufficiency in clinical development and advancing indigenous pharmaceutical agents
“Innovations played a major role in India’s pandemic response”
Dr Taslimarif Saiyed, CEO and Director, Centre for Cellular and Molecular Platforms (C-CAMP), shares his thoughts on the India’s biotech R&D
India developed four indigenous vaccines in just two years: Dr Jitendra...
DBT through “Mission COVID Suraksha”, delivered four vaccines, augmented the manufacturing of Covaxin
The Rising Vaccine Superpower: India’s phenomenal rise in the new vaccine...
Garnering a massive chunk of revenue owing to Covid-19 push, India’s indigenous vaccines now proudly dominate the biopharma segment. Here we analyze the fresh impetus and the outlook
Up to 7% TB patients stopped taking medicines during lockdown, claims...
A new study by the researchers at The George Institute for Global Health India examines the possible adverse impact of the Covid-19 pandemic restrictions on India's Tuberculosis (TB) control programme
Increase in cases of Avascular Necrosis in post COVID patients leading...
Patient data from Artemis Hospital, Gurugram reveals 20% increase in AVN cases, and the requirement of surgery has also increased by roughly 20%
Doctors report spike in cases of heart attack, heart failure post...
The people who had severe form of Covid need to take precautions, says Dr. LK Jha of Sarvodaya Hospital
Notable increase in Avascular Necrosis cases in post COVID patients
Male patients in the age group of 45-60 years most affected
First ‘Made in India’ cervical cancer vaccine in offing
It will be administered with a two-dose schedule for girls in the age group of 9-14 and a three-dose schedule for girls and women in the age group of 15-26